camptothecin has been researched along with tretinoin in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (28.57) | 18.2507 |
| 2000's | 7 (33.33) | 29.6817 |
| 2010's | 7 (33.33) | 24.3611 |
| 2020's | 1 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Kondo, K; Oishi, M; Tsuneizumi, K; Watanabe, T | 1 |
| Tsukagoshi, S | 1 |
| Hashimoto, S; Jing, Y; Nakajo, S; Nakaya, K | 1 |
| Gorczyca, W; Melamed, MR; Pizzolo, JG; Qiao, L | 1 |
| Bertrand, R; Kohn, KW; Pommier, Y; Solary, E | 1 |
| Slack, JL; Yu, M | 1 |
| Aller, P; de Blas, E; Galán, A; Garcia-Bermejo, L; Vilaboa, NE | 1 |
| Laconi, C; Lovisolo, GA; Marino, C; Mosiello, L; Negroni, A; Pirozzoli, MC | 1 |
| Limper, AH | 1 |
| Laconi, C; Lovisolo, GA; Marino, C; Merola, P; Negroni, A; Pinto, R | 1 |
| Cao, D; Ichikawa, H; Kadomatsu, K; Kishida, S; Kiyonari, S; Murakami-Tonami, Y; Nakaguro, M; Nakamura, S; Takeuchi, I | 1 |
| Bernardi, R; Coltella, N; Ponente, M; Ponzoni, M; Valsecchi, R | 1 |
| Huang, Y; Li, L; Wu, L; Yang, Q; Zhou, Z | 1 |
| Emami, J; Hasanzadeh, F; Maghzi, P; Mirian, M; Rostami, M; Sadeghi, H | 1 |
| Lin, S; Liu, H; Mo, R; Shen, S; Xu, X; Zhang, C; Zhang, Y | 1 |
2 review(s) available for camptothecin and tretinoin
| Article | Year |
|---|---|
[Recent development of new anticancer drugs in Japan].
Topics: Aminopterin; Antineoplastic Agents; Camptothecin; Cisplatin; Cytarabine; Irinotecan; Methotrexate; Paclitaxel; Tretinoin; Tubulin Modulators; Vinblastine; Vinorelbine | 1993 |
Chemotherapy-induced lung disease.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Bleomycin; Busulfan; Camptothecin; Cyclophosphamide; Humans; Iatrogenic Disease; Interferons; Irinotecan; Lung Diseases; Methotrexate; Mitomycin; Nitrosamines; Respiratory Function Tests; Tretinoin | 2004 |
19 other study(ies) available for camptothecin and tretinoin
| Article | Year |
|---|---|
Identifying off-target effects and hidden phenotypes of drugs in human cells.
Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship | 2006 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Induction of in vitro differentiation of mouse embryonal carcinoma (F9) cells by inhibitors of topoisomerases.
Topics: Animals; Blotting, Western; Camptothecin; Cell Differentiation; Cell Line; DNA Topoisomerases, Type I; Dose-Response Relationship, Drug; Genistein; In Vitro Techniques; Isoflavones; Laminin; Lewis X Antigen; Mice; Protein-Tyrosine Kinases; Teniposide; Teratoma; Tissue Plasminogen Activator; Topoisomerase I Inhibitors; Tretinoin | 1991 |
Topoisomerase inhibitors potentiate the effect of retinoic acid on cell growth inhibition and induction of differentiation of leukemia HL-60 cells.
Topics: Camptothecin; Carboxylesterase; Carboxylic Ester Hydrolases; Cell Cycle; Cell Differentiation; DNA, Neoplasm; Drug Synergism; Etoposide; Growth Inhibitors; Humans; In Vitro Techniques; Leukemia, Myeloid; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Tretinoin; Tumor Cells, Cultured | 1994 |
p145 expression during the cell cycle in HL-60 cell line and normal human lymphocytes: effects of camptothecin, vinblastine, cycloheximide, actinomycin D, retinoic acid and DMSO.
Topics: Antigens, Nuclear; Antineoplastic Agents; Camptothecin; Cell Cycle; Cell Differentiation; Cycloheximide; Dactinomycin; Dimethyl Sulfoxide; Flow Cytometry; Humans; Lymphocyte Activation; Lymphocytes; Nuclear Proteins; Tretinoin; Tumor Cells, Cultured; Vinblastine | 1993 |
Differential induction of apoptosis in undifferentiated and differentiated HL-60 cells by DNA topoisomerase I and II inhibitors.
Topics: Amsacrine; Apoptosis; Camptothecin; Cell Differentiation; DNA; DNA Damage; Etoposide; Humans; Leukemia, Promyelocytic, Acute; Tetradecanoylphorbol Acetate; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Tretinoin; Tumor Cells, Cultured | 1993 |
Constitutive expression of the promyelocytic leukemia-associated oncogene PML-RARalpha in TF1 cells: isoform-specific and retinoic acid-dependent effects on growth, bcl-2 expression, and apoptosis.
Topics: Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Camptothecin; Cell Differentiation; Cell Division; Cell Survival; Genes, bcl-2; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Neoplasm Proteins; Oncogene Proteins, Fusion; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; Transfection; Translocation, Genetic; Tretinoin; Tumor Cells, Cultured | 1998 |
Uncoupling of apoptosis and Jun/AP-1 activity in human promonocytic cells treated with DNA-damaging and stress-inducing agents.
Topics: Apoptosis; Cadmium Chloride; Camptothecin; Colforsin; Cyclic AMP; DNA Damage; Enzyme Inhibitors; Etoposide; Gene Expression; Heating; Humans; Monocytes; Proto-Oncogene Proteins c-jun; Theophylline; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Transcription Factor AP-1; Tretinoin; U937 Cells; Uncoupling Agents | 2000 |
Effects of 50 Hz electromagnetic field exposure on apoptosis and differentiation in a neuroblastoma cell line.
Topics: Apoptosis; Camptothecin; Cell Differentiation; Cell Division; Cell Line, Tumor; Dose-Response Relationship, Radiation; Drug Tolerance; Electricity; Electromagnetic Fields; Humans; Neuroblastoma; Tretinoin | 2003 |
Proliferation and apoptosis in a neuroblastoma cell line exposed to 900 MHz modulated radiofrequency field.
Topics: Antineoplastic Agents; Apoptosis; Camptothecin; Cell Differentiation; Cell Line, Tumor; Cell Phone; Cell Proliferation; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Electromagnetic Fields; Environmental Exposure; Humans; Microwaves; Neuroblastoma; Radiation Dosage; Radio Waves; Tretinoin | 2006 |
Nucleolar protein PES1 is a marker of neuroblastoma outcome and is associated with neuroblastoma differentiation.
Topics: Animals; Apoptosis; Camptothecin; Cell Cycle; Cell Cycle Proteins; Cell Proliferation; Humans; Mice; Mice, Transgenic; N-Myc Proto-Oncogene Protein; Neuroblastoma; Prognosis; Proteins; Proto-Oncogene Proteins; RNA Interference; RNA-Binding Proteins; RNA, Small Interfering; Tretinoin; Tumor Cells, Cultured | 2015 |
Synergistic Leukemia Eradication by Combined Treatment with Retinoic Acid and HIF Inhibition by EZN-2208 (PEG-SN38) in Preclinical Models of PML-RARα and PLZF-RARα-Driven Leukemia.
Topics: Animals; Arsenic Trioxide; Arsenicals; Camptothecin; Cell Differentiation; Cell Movement; Disease Models, Animal; Drug Resistance, Neoplasm; Drug Synergism; Gene Expression Regulation, Neoplastic; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Leukemia, Promyelocytic, Acute; Mice; Mutation; Neoplasm Proteins; Oncogene Proteins, Fusion; Oxides; Polyethylene Glycols; Tretinoin | 2015 |
Subcellular co-delivery of two different site-oriented payloads for tumor therapy.
Topics: Acrylamides; Animals; Antineoplastic Agents; Apoptosis; Camptothecin; Cell Line, Tumor; DNA Damage; Docetaxel; Drug Delivery Systems; Humans; Male; Mice; Mice, Inbred BALB C; Micelles; Neoplasms; NIH 3T3 Cells; Organosilicon Compounds; Polymers; Taxoids; Tretinoin; Xenograft Model Antitumor Assays | 2017 |
PLGA-PEG-RA-based polymeric micelles for tumor targeted delivery of irinotecan.
Topics: Camptothecin; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Carriers; Drug Delivery Systems; Hep G2 Cells; HT29 Cells; Humans; Irinotecan; Lactic Acid; Liver Neoplasms; Micelles; Nanoparticles; Particle Size; Polyethylene Glycols; Polyglactin 910; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Tretinoin | 2018 |
A nanotherapeutic strategy to overcome chemotherapeutic resistance of cancer stem-like cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Camptothecin; Cell Differentiation; Drug Delivery Systems; Drug Liberation; Drug Resistance, Neoplasm; Female; Humans; Mice, Inbred BALB C; Nanomedicine; Nanoparticles; Neoplastic Stem Cells; Rats, Wistar; Tissue Distribution; Tretinoin; Xenograft Model Antitumor Assays | 2021 |